| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▲ | 1.04▲ | 1.04▲ | 1.05▲ | 1.07▲ |
| MA10 | 1.04▲ | 1.04▲ | 1.04▲ | 1.04▲ | 1.19▼ |
| MA20 | 1.04▲ | 1.04▲ | 1.04▲ | 1.07▲ | 1.34▼ |
| MA50 | 1.04▲ | 1.08▲ | 1.10▼ | 1.24▼ | 1.83▼ |
| MA100 | 1.11▼ | 1.16▼ | 1.19▼ | 1.37▼ | 1.99▼ |
| MA200 | 1.19▼ | 1.28▼ | 1.31▼ | 1.75▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.007▲ | 0.009▲ | 0.016▲ | -0.012▼ |
| RSI | 76.745▲ | 64.299▲ | 59.560▲ | 47.837▼ | 36.832▼ |
| STOCH | 33.333 | 27.778 | 38.611 | 71.039 | 10.185▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | 0.000▲ | -78.571▼ |
| CCI | 375.078▲ | 278.287▲ | 245.098▲ | 210.735▲ | -89.820 |
|
Wednesday, October 21, 2026 04:30 AM
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced completion of the database lock for Cohort A of QUILT-2.005 (NCT02138734), its randomized, controlled, registrational trial ...
|
|
Friday, October 16, 2026 09:20 AM
ImmunityBio has secured early FDA label expansion for Anktiva in BCG-unresponsive NMIBC. Check out why IBRX stock is a hold.
|
|
Wednesday, October 14, 2026 01:18 PM
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/26 | 1.10 | 1.10 | 1.10 | 1.10 | 2,120 |
| 20/10/26 | 1.03 | 1.08 | 1.03 | 1.08 | 3,248 |
| 19/10/26 | 1.02 | 1.065 | 1.02 | 1.04 | 39,689 |
| 16/10/26 | 1.0301 | 1.0301 | 1.02 | 1.02 | 5,409 |
| 15/10/26 | 1.015 | 1.035 | 1.015 | 1.03 | 4,503 |
| 14/10/26 | 1.00 | 1.02 | 0.9977 | 1.00 | 26,811 |
| 13/10/26 | 1.01 | 1.04 | 0.9999 | 1.02 | 10,157 |
| 12/10/26 | 1.03 | 1.035 | 1.01 | 1.03 | 18,909 |
| 09/10/26 | 1.07 | 1.07 | 1.0321 | 1.05 | 3,020 |
| 08/10/26 | 0.99 | 1.06 | 0.95 | 1.045 | 30,596 |
|
|
||||
|
|
||||
|
|